Mascanfroni Ivan D, Takenaka Maisa C, Yeste Ada, Patel Bonny, Wu Yan, Kenison Jessica E, Siddiqui Shafiuddin, Basso Alexandre S, Otterbein Leo E, Pardoll Drew M, Pan Fan, Priel Avner, Clish Clary B, Robson Simon C, Quintana Francisco J
Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Gastroenterology, Hepatology and Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Nat Med. 2015 Jun;21(6):638-46. doi: 10.1038/nm.3868. Epub 2015 May 25.
Our understanding of the pathways that regulate lymphocyte metabolism, as well as the effects of metabolism and its products on the immune response, is still limited. We report that a metabolic program controlled by the transcription factors hypoxia inducible factor-1α (HIF1-α) and aryl hydrocarbon receptor (AHR) supports the differentiation of type 1 regulatory T cell (Tr1) cells. HIF1-α controls the early metabolic reprograming of Tr1 cells. At later time points, AHR promotes HIF1-α degradation and takes control of Tr1 cell metabolism. Extracellular ATP (eATP) and hypoxia, linked to inflammation, trigger AHR inactivation by HIF1-α and inhibit Tr1 cell differentiation. Conversely, CD39 promotes Tr1 cell differentiation by depleting eATP. CD39 also contributes to Tr1 suppressive activity by generating adenosine in cooperation with CD73 expressed by responder T cells and antigen-presenting cells. These results suggest that HIF1-α and AHR integrate immunological, metabolic and environmental signals to regulate the immune response.
J Autoimmun. 2018-8-8
Proc Natl Acad Sci U S A. 2020-5-14
J Mol Med (Berl). 2017-5-26
Clin Exp Allergy. 2015-6
Cell Mol Immunol. 2025-5-26
Bioinformatics. 2025-6-2
Nat Rev Drug Discov. 2025-4-17
Front Immunol. 2025-3-6
Rev Med Virol. 2025-3
Nature. 2025-2
Curr Top Microbiol Immunol. 2014
Nature. 2014-5-15
Nat Commun. 2014-5-6
Annu Rev Immunol. 2014
Science. 2013-10-11
Annu Rev Pathol. 2013-8-7